Tricuspid regurgitation surgery: Difference between revisions

Jump to navigation Jump to search
No edit summary
(/* 2008 ACC/AHA Guidelines for the Management of Patients with Valvular Heart Disease (DO NOT EDIT){{cite journal |author=Bonow RO, Carabello BA, Chatterjee K, et al. |title=2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the...)
Line 44: Line 44:
|}
|}


==2008 ACC/AHA Guidelines for the Management of Patients with Valvular Heart Disease (DO NOT EDIT)<ref name="pmid18820172">{{cite journal |author=Bonow RO, Carabello BA, Chatterjee K, ''et al.'' |title=2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons |journal=Circulation |volume=118 |issue=15 |pages=e523–661 |year=2008 |month=October |pmid=18820172 |doi=10.1161/CIRCULATIONAHA.108.190748 |url=}}</ref>==
==2008 ACC/AHA Guidelines for the Management of Patients with Valvular Heart Disease - Indications for Intervention in Tricuspid Regurgitation (DO NOT EDIT)<ref name="pmid18820172">{{cite journal |author=Bonow RO, Carabello BA, Chatterjee K, ''et al.'' |title=2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons |journal=Circulation |volume=118 |issue=15 |pages=e523–661 |year=2008 |month=October |pmid=18820172 |doi=10.1161/CIRCULATIONAHA.108.190748 |url=}}</ref>==


{|class="wikitable"
{|class="wikitable"

Revision as of 17:52, 30 October 2012

WikiDoc Resources for Tricuspid regurgitation surgery

Articles

Most recent articles on Tricuspid regurgitation surgery

Most cited articles on Tricuspid regurgitation surgery

Review articles on Tricuspid regurgitation surgery

Articles on Tricuspid regurgitation surgery in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Tricuspid regurgitation surgery

Images of Tricuspid regurgitation surgery

Photos of Tricuspid regurgitation surgery

Podcasts & MP3s on Tricuspid regurgitation surgery

Videos on Tricuspid regurgitation surgery

Evidence Based Medicine

Cochrane Collaboration on Tricuspid regurgitation surgery

Bandolier on Tricuspid regurgitation surgery

TRIP on Tricuspid regurgitation surgery

Clinical Trials

Ongoing Trials on Tricuspid regurgitation surgery at Clinical Trials.gov

Trial results on Tricuspid regurgitation surgery

Clinical Trials on Tricuspid regurgitation surgery at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Tricuspid regurgitation surgery

NICE Guidance on Tricuspid regurgitation surgery

NHS PRODIGY Guidance

FDA on Tricuspid regurgitation surgery

CDC on Tricuspid regurgitation surgery

Books

Books on Tricuspid regurgitation surgery

News

Tricuspid regurgitation surgery in the news

Be alerted to news on Tricuspid regurgitation surgery

News trends on Tricuspid regurgitation surgery

Commentary

Blogs on Tricuspid regurgitation surgery

Definitions

Definitions of Tricuspid regurgitation surgery

Patient Resources / Community

Patient resources on Tricuspid regurgitation surgery

Discussion groups on Tricuspid regurgitation surgery

Patient Handouts on Tricuspid regurgitation surgery

Directions to Hospitals Treating Tricuspid regurgitation surgery

Risk calculators and risk factors for Tricuspid regurgitation surgery

Healthcare Provider Resources

Symptoms of Tricuspid regurgitation surgery

Causes & Risk Factors for Tricuspid regurgitation surgery

Diagnostic studies for Tricuspid regurgitation surgery

Treatment of Tricuspid regurgitation surgery

Continuing Medical Education (CME)

CME Programs on Tricuspid regurgitation surgery

International

Tricuspid regurgitation surgery en Espanol

Tricuspid regurgitation surgery en Francais

Business

Tricuspid regurgitation surgery in the Marketplace

Patents on Tricuspid regurgitation surgery

Experimental / Informatics

List of terms related to Tricuspid regurgitation surgery

For the main page of tricuspid regurgitation, click here.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

In most cases, surgery is not indicated since the root problem lies with a dilated or damaged right ventricle. Medical therapy with diuretics is the mainstay of treatment. Unfortunately, this can lead to volume depletion and decreased cardiac output. Indeed, one must often accept a certain degree of symptomatic tricuspid insufficiency in order to prevent a decrease in cardiac output. Treatment with medicines to reduce cardiac afterload may also be of benefit but a similar risk of depressed cardiac output applies.

2008 ACC/AHA Guidelines for the Management of Patients with Valvular Heart Disease - Tricuspid Valve Replacement in Triscupid Regurgitation (DO NOT EDIT) [1]

Class I
"1. Tricuspid valve repair is beneficial for severe TR in patients with mitral valve disease requiring mitral valve surgery. (Level B)"
Class III
"1. Tricuspid valve replacement or annuloplasty is not indicated in asymptomatic patients with TR whose pulmonary artery systolic pressure is less than 60 mm Hg in the presence of a normal mitral valve. (Level C)"
"2. Tricuspid valve replacement or annuloplasty is not indicated in patients with mild primary TR. (Level C)"
Class IIa
"1. Tricuspid valve replacement or annuloplasty is reasonable for severe primary TR when symptomatic. (Level C)"
"2. Tricuspid valve replacement is reasonable for severe TR secondary to diseased/abnormal tricuspid valve leaflets not amenable to annuloplasty or repair. (Level C)"
Class IIb
"1. Tricuspid valve replacement or annuloplasty is reasonable for severe primary TR when symptomatic. (Level C)"

2008 ACC/AHA Guidelines for the Management of Patients with Valvular Heart Disease - Indications for Intervention in Tricuspid Regurgitation (DO NOT EDIT)[1]

Class I
"1. Surgery for severe TR is recommended for adolescent and young adult patients with deteriorating exercise capacity (NYHA functional class III or IV). (Level C)"
"2. Surgery for severe TR is recommended for adolescent and young adult patients with progressive cyanosis and arterial saturation less than 80% at rest or with exercise. (Level C)"
"3. Interventional catheterization closure of the atrial communication is recommended for the adolescent or young adult with TR who is hypoxemic at rest and with exercise intolerance due to increasing hypoxemia with exercise, when the tricuspid valve appears difficult to repair surgically. (Level C)"
Class IIa
"1. Surgery for severe TR is reasonable in adolescent and young adult patients with NYHA functional class II symptoms if the valve appears to be repairable. (Level C)"
"2. Surgery for severe TR is reasonable in adolescent and young adult patients with atrial fibrillation. (Level C)"
Class IIb
"1. Surgery for severe TR may be considered in asymptomatic adolescent and young adult patients with increasing heart size and a cardiothoracic ratio of more than 65%. (Level C)"
"2. Surgery for severe TR may be considered in asymptomatic adolescent and young adult patients with stable heart size and an arterial saturation of less than 85% when the tricuspid valve appears repairable. (Level C)"
"3. In adolescent and young adult patients with TR who are mildly cyanotic at rest but who become very hypoxemic with exercise, closure of the atrial communication by interventional catheterization may be considered when the valve does not appear amenable to repair. (Level C)"
"4. If surgery for Ebstein’s anomaly is planned in adolescents and young adult patients (tricuspid valve repair or replacement), a preoperative electrophysiological study may be considered to identify accessory pathways. If present, these may be considered for mapping and ablation either preoperatively or at the time of surgery. (Level C)"

Sources

  • 2008 ACC/AHA Guidelines incorporated into the 2006 guidelines for the management of patients with valvular heart disease [1]

References

  1. 1.0 1.1 1.2 Bonow RO, Carabello BA, Chatterjee K; et al. (2008). "2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". Circulation. 118 (15): e523–661. doi:10.1161/CIRCULATIONAHA.108.190748. PMID 18820172. Unknown parameter |month= ignored (help)

Template:WH Template:WS